Home
Vestal Point Capital reported a 9.95% stake in Dianthus Therapeutics DNTH · 3,200,000 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 9.95%
- Last report
- 5.3% · filed 25/05/15
- Shares held
- 3,200,000 sh
- Class
- Common Stock, par value $0.001 per share
- Holder
- Vestal Point Capital
- Event date
- 25/06/30
- Filed
- 25/08/14
9.95% stake · +4.7pp from the last report
- Stake
- 9.95%
- Last report
- 5.3%
- Since last report
- +4.7pp
Dianthus Therapeutics trades, last 26 weeks
What else happened in Dianthus Therapeutics around then
Filed or reported within 30 days of the trade day · 25/05/31~25/07/30Vestal Point Capital's other 5% stake reports
- Vestal Point Capital
5% stakeMonte Rosa Therapeutics
5% stakeMonte Rosa Therapeutics
GLUE
5.4% stake
4,600,000 sh
5.4% stake
Filed 08/14
- Vestal Point Capital
5% stakeMyriad Genetics
5% stakeMyriad Genetics
MYGN
6.1% stake
5,735,000 sh
6.1% stake
Filed 08/14
- Vestal Point Capital
5% stakeSolid Biosciences
5% stakeSolid Biosciences
SLDB
4.8% stake
4,833,796 sh
4.8% stake
Filed 08/14
- Vestal Point Capital
5% stakeImmunocore Holdings
5% stakeImmunocore Holdings
IMCR
3.5% stake
1,800,000 sh
3.5% stake
Filed 08/14
- Vestal Point Capital
5% stakeNurix Therapeutics
5% stakeNurix Therapeutics
NRIX
7.8% stake
8,050,000 sh
7.8% stake
Filed 08/14
